Clinical Trial Update: Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ScTILs (genetically modified tumor infiltrating lymphocytes) for cervical and ovarian cancers (and malignant trophoblastic tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Malignant Trophoblastic Tumor
• Ovarian Cancer

Drugs mentioned

• ScTIL (scTIL)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cervical Cancer, Ovarian Cancer | Phase 2 | Status: UNKNOWN